Hmm do you want to go check out iova or adap? They just got approved in the US. Adap is actually a UK based company. But sure keep believing that BS you spout about UK as ideal launching pad for autologous products. Who is the one speculating? Why would you choose to go to a small market that doesn't pay? I just debunked your idea that autologous Products aren't approved in the the largest market aka the US. But okay pumper wink wink sure I am living in denial....eye roll.
I’ve been here many years, and when asked many years ago where an artisan novel autologous biologic such as this might be best developed and launched, I said the UK, for several reasons. It may have been even before I started posting here
Friendly question. You have been posting here since mid-2013. Back then the UK was still part of the EU so launching DCVAXL would have meant launching in the EU. Is that what you meant?
The best source for this is Liau. She has been on record saying that she is unsure if the absence of individual patient-level data would cause problems for a BLA. A US approval will take longer than expected as such is the way of NWBO.